Annual Retained Earnings
-$201.37 M
-$39.14 M-24.13%
September 30, 2024
Summary
- As of February 8, 2025, CTXR annual retained earnings is -$201.37 million, with the most recent change of -$39.14 million (-24.13%) on September 30, 2024.
- During the last 3 years, CTXR annual retained earnings has fallen by -$105.32 million (-109.66%).
- CTXR annual retained earnings is now -481646.89% below its all-time high of -$41.80 thousand, reached on September 30, 2011.
Performance
CTXR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$201.37 M
-$10.79 M-5.66%
September 30, 2024
Summary
- As of February 8, 2025, CTXR quarterly retained earnings is -$201.37 million, with the most recent change of -$10.79 million (-5.66%) on September 30, 2024.
- Over the past year, CTXR quarterly retained earnings has dropped by -$10.79 million (-5.66%).
- CTXR quarterly retained earnings is now -514913.30% below its all-time high of -$39.10 thousand, reached on June 30, 2011.
Performance
CTXR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CTXR Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.1% | -5.7% |
| 3 y3 years | -109.7% | -5.7% |
| 5 y5 years | -279.6% | -5.7% |
CTXR Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -109.7% | at low | -91.3% | at low |
| 5 y | 5-year | -279.6% | at low | -234.8% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Citius Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -$201.37 M(+24.1%) | -$201.37 M(+5.7%) |
| Jun 2024 | - | -$190.58 M(+5.9%) |
| Mar 2024 | - | -$180.01 M(+5.0%) |
| Dec 2023 | - | -$171.46 M(+5.7%) |
| Sep 2023 | -$162.23 M(+25.1%) | -$162.23 M(+6.5%) |
| Jun 2023 | - | -$152.29 M(+5.9%) |
| Mar 2023 | - | -$143.81 M(+7.9%) |
| Dec 2022 | - | -$133.28 M(+2.8%) |
| Sep 2022 | - | -$129.69 M(+6.6%) |
| Sep 2022 | -$129.69 M(+35.0%) | - |
| Jun 2022 | - | -$121.70 M(+7.9%) |
| Mar 2022 | - | -$112.83 M(+7.2%) |
| Dec 2021 | - | -$105.27 M(+9.6%) |
| Sep 2021 | -$96.05 M(+36.1%) | -$96.05 M(+5.4%) |
| Jun 2021 | - | -$91.09 M(+6.8%) |
| Mar 2021 | - | -$85.26 M(+5.1%) |
| Dec 2020 | - | -$81.14 M(+14.9%) |
| Sep 2020 | -$70.59 M(+33.1%) | -$70.59 M(+6.2%) |
| Jun 2020 | - | -$66.47 M(+3.0%) |
| Mar 2020 | - | -$64.57 M(+7.4%) |
| Dec 2019 | - | -$60.14 M(+13.4%) |
| Sep 2019 | -$53.05 M(+31.8%) | -$53.05 M(+1.7%) |
| Jun 2019 | - | -$52.17 M(+9.2%) |
| Mar 2019 | - | -$47.76 M(+8.2%) |
| Dec 2018 | - | -$44.13 M(+9.6%) |
| Sep 2018 | -$40.26 M | -$40.26 M(+7.6%) |
| Jun 2018 | - | -$37.41 M(+5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | -$35.39 M(+14.3%) |
| Dec 2017 | - | -$30.97 M(+11.7%) |
| Sep 2017 | -$27.72 M(+59.9%) | -$27.72 M(+12.3%) |
| Jun 2017 | - | -$24.68 M(+10.9%) |
| Mar 2017 | - | -$22.26 M(+14.1%) |
| Dec 2016 | - | -$19.51 M(+12.6%) |
| Sep 2016 | -$17.34 M(+91.8%) | -$17.34 M(+17.6%) |
| Jun 2016 | - | -$14.75 M(+32.5%) |
| Mar 2016 | - | -$11.13 M(+8.5%) |
| Dec 2015 | - | -$10.26 M(+13.5%) |
| Sep 2015 | -$9.04 M(+47.3%) | -$9.04 M(+11.2%) |
| Jun 2015 | - | -$8.13 M(+11.3%) |
| Mar 2015 | - | -$7.31 M(+5.0%) |
| Dec 2014 | - | -$6.96 M(+13.4%) |
| Sep 2014 | -$6.14 M(+6347.8%) | -$6.14 M(+5385.5%) |
| Jun 2014 | - | -$111.90 K(+6.0%) |
| Mar 2014 | - | -$105.60 K(+10.5%) |
| Dec 2013 | - | -$95.60 K(+0.4%) |
| Sep 2013 | -$95.20 K(+49.2%) | -$95.20 K(+19.1%) |
| Jun 2013 | - | -$79.90 K(+5.8%) |
| Mar 2013 | - | -$75.50 K(+15.6%) |
| Dec 2012 | - | -$65.30 K(+2.4%) |
| Sep 2012 | -$63.80 K(+52.6%) | -$63.80 K(+9.1%) |
| Jun 2012 | - | -$58.50 K(+13.4%) |
| Mar 2012 | - | -$51.60 K(+16.2%) |
| Dec 2011 | - | -$44.40 K(+6.2%) |
| Sep 2011 | -$41.80 K | -$41.80 K(+6.9%) |
| Jun 2011 | - | -$39.10 K |
FAQ
- What is Citius Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual retained earnings year-on-year change?
- What is Citius Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly retained earnings year-on-year change?
What is Citius Pharmaceuticals annual retained earnings?
The current annual retained earnings of CTXR is -$201.37 M
What is the all time high annual retained earnings for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual retained earnings is -$41.80 K
What is Citius Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, CTXR annual retained earnings has changed by -$39.14 M (-24.13%)
What is Citius Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of CTXR is -$201.37 M
What is the all time high quarterly retained earnings for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly retained earnings is -$39.10 K
What is Citius Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, CTXR quarterly retained earnings has changed by -$10.79 M (-5.66%)